Toward decoding the principles of cancer metastasis circuits

Cancer Research

Volumn 74, Issue 17, 2014, Pages 4574-4587

  Lu, Mingyang ^a   Jolly, Mohit Kumar ^a,b   Onuchic, Jose' ^a,c,d,e   Ben Jacob, Eshel ^a,e,f  

^a TEL AVIV UNIVERSITY   (Israel)

^b Departments of Bioengineering   (United States)

^c Rice u   (United States)

^d Departments of Chemistry   (United States)

^e RICE UNIVERSITY   (United States)

^f School of Physics and Astronomy 116 Church Street SE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEODOMAIN PROTEIN; MICRORNA; MIRN200 MICRORNA, HUMAN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR; ZEB1 PROTEIN, HUMAN;

CELL MOTION; EPITHELIAL MESENCHYMAL TRANSITION; GENE REGULATORY NETWORK; GENETICS; HUMAN; METASTASIS; PATHOLOGY;

CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; GENE REGULATORY NETWORKS; HOMEODOMAIN PROTEINS; HUMANS; MICRORNAS; NEOPLASM METASTASIS; TRANSCRIPTION FACTORS;

EID: 84907059374     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-3367     Document Type: Article

References (100)

1. Balazsi G, van Oudenaarden A, Collins JJ. Cellular decision making and biological noise: from microbes to mammals. Cell 2011;144: 910-25.
2. Zhou JX, Huang S. Understanding gene circuits at cell-fate branch points for rational cell programming. Trends Genet 2011;27: 55-62.
3. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005;122:947-56.
4. Holland JD, Klaus A, Garratt AN, Birchmeier W. Wnt signaling in stem and cancer stem cells. Curr Opin Cell Biol 2013;25: 254-64.
5. De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 2013;13:97-110.
6. Thiery JP, Acloque H, Huang RYJ, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009;139:871-90.
7. Gupta GP, Massague J. Cancer Metastasis: building a framework. Cell 2006;127:679-95.
8. Friedl P, Gilmour D. Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 2009;10:445-57.
9. Nakaya Y, Sheng G. EMT in developmental morphogenesis. Cancer Lett 2013;341:9-15.
10. Micalizzi DS, Farabaugh SM, Ford HL. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 2010;15:117-34.
11. Savagner P. The epithelial-mesenchymal transition (EMT) phenomenon. Ann Oncol 2010;21(Suppl 7):vii89-92.
12. Revenu C, Gilmour D. EMT 2.0: shaping epithelia through collective migration. Curr Opin Genet Dev 2009;19:338-42.
13. Faculty TA, Futterman M, Fulfillment IP. Evidence for partial epithelialto- mesenchyamal transition (pEMT) and recruitment of motile blastoderm edge cells during avian epiboly. Dev Dyn 2011;240:1502-11.
14. Johnen N, Francart M-E, Thelen N, Cloes M, Thiry M. Evidence for a partial epithelial-mesenchymal transition in postnatal stages of rat auditory organ morphogenesis. Histochem Cell Biol 2012;138: 477-88.
15. Christiansen JJ, Rajasekaran AK. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 2006;66:8319-26.
16. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420-8.
17. Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013;339:580-4.
18. Samavarchi-Tehrani P, Folipour A, David L, Sung HK, Beyer TA, et al. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 2010;7:64-77.
19. Li R, Liang J, Ni S, Zhou T, Qing X, Li H, et al. A mesenchymal-toepithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblats. Cell Stem Cell 2010;7:51-63.
20. Theys J, Jutten B, Habets R, Paesmans K, Groot AJ, Lambin P, et al. E-cadherin loss associated with EMT promotes radioresistance in human tumor cells. Radiother Oncol 2011;99:392-7.
21. Kurrey NK, Jalgaonkar SP, Joglekar AV, Ghanate AD, Chaskar PD, et al. Snail and Slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stemlike phenotype in ovarian cancer cells. Stem Cells 2009;27: 2059-68.
22. Mani SA, Guo W, Liao M-J, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008;133:704-15.
23. Morel A-P, Liévre M, Thomas C, Hinkal G, Ansieau S, Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 2008;3:e2888.
24. Bao B, Wang Z, Ali S, Kong D, Li Y, Ahmad A, et al. Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Lett 2011; 307:26-36.
25. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial- mesenchymal transitions. Nat Rev Mol Cell Biol 2006;7:131-42.
26. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007;7:415-28.
27. Gregory PA, Bracken CP, Smith E, Bert AG, Wright JA, Roslan S, et al. An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol Biol Cell 2011;22:1686-98.
28. Lundgren K, Nordenskjöld B, Landberg G. Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer. Br J Cancer 2009;101:1769-81.
29. Chang C-J, Chao C-H, Xia W, Yang J-Y, Xiong Y, Li C-W, et al. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol 2011;13:317-23.
30. Araki S, Eitel JA, Batuello CN, Bijangi-Vishehsaraei K, Xie X-J, Danielpour D, et al. TGF-beta1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer. J Clin Invest 2010;120:290-302.
31. Brabletz S, Brabletz T. The ZEB/miR-200 feedback loop-a motor of cellular plasticity in development and cancer? EMBO Rep 2010;11: 670-7.
32. Brabletz S, Bajdak K, Meidhof S, Burk U, Niedermann G, Firat E, et al. The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells. EMBO J 2011;30:770-82.
33. Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF, et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 2008;68:7846-54.
34. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, et al.A reciprocal repression between ZEB1 andmembers of the miR- 200 family promotes EMT and invasion in cancer cells. EMBO Rep 2008;9:582-9.
35. Siemens H, Jackstadt R, Hünten S, Kaller M, Menssen A, Götz U, et al. miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions. Cell Cycle 2011;10: 4256-71.
36. Lu M, Jolly MK, Gomoto R, Huang B, Onuchic J, Ben-Jacob E. Tristability in cancer-associated microRNA-TF chimera toggle switch. J Phys Chem B 2013;117:13164-74.
37. Hurteau GJ, Carlson JA, Roos E, Brock GJ. Stable expression of miR- 200c alone is sufficient to regulate TCF8 (ZEB1) and restore E-cadherin expression. Cell Cycle 2009;8:2064-9.
38. Guaita S, Puig I, Franci C, Garrido M, Dominguez D, Batlle E, et al. Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J Biol Chem 2002;277:39209-16.
39. Peiro S, Escriva M, Puig I, Barbera MJ, Dave N, Herranz N, et al. Snail1 transcriptional repressor binds to its own promoter and controls its expression. Nucleic Acids Res 2006;34:2077-84.
40. Wels C, Joshi S, Koefinger P, Bergler H, Schaider H. Transcriptional activation of ZEB1 by slug leads to cooperative regulation of the epithelial-mesenchymal transition-like phenotype in melanoma. J Invest Dermatol 2011;131:1877-85.
41. Braun J, Hoang-Vu C, Dralle H, Hüttelmaier S. Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas. Oncogene 2010;29:4237-44.
42. Aguda BD, Kim Y, Piper-Hunter MG, Friedman A, Marsh CB. Micro- RNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proc Natl Acad Sci U S A 2008;105:19678-83.
43. Li Y, Chen Y, Zhang H, Li Y. MicroRNA-mediated positive feedback loop and optimized bistable switch in a cancer network involving miR- 17-92. PLoS ONE 2011;6:e26302.
44. Zhou P, Liu Z, Cai S, Wang R. Mechanisms generating bistability and oscillations in microRNA-mediated motifs. Phys Rev E Stat Nonlin Soft Matter Phys 2012;85:041916.
45. Tian X-J, Zhang H, Xing J.Coupled reversible and irreversible bistable switches underlying TGFb-induced epithelial to mesenchymal transition. Biophys J 2013;105:1079-89.
46. Verma M, Karimiani EG, Byers RJ, Rehman S, Westerhoff HV, Day PJR. Mathematical modelling of miRNA mediated BCR.ABL protein regulation in chronic myeloid leukaemia vis-a-vis therapeutic strategies. Integr Biol 2013;5:543-54.
47. Kang H-W, Crawford M, Fabbri M, Nuovo G, Garofalo M, Nana- Sinkam SP, et al. A mathematical model for microRNA in lung cancer. PLoS ONE 2013;8:e53663.
48. Lai X, Wolkenhauer O, Vera J. Modeling miRNA regulation in cancer signaling systems: miR-34a regulation of the p53/Sirt1 signaling module. Methods Mol Biol 2012;880:87-108.
49. Khanin R, Vinciotti V. Computational modeling of post-transcriptional gene regulation by MicroRNAs. J Comput Biol 2008;15:305-16.
50. Wei Z, Jiang S, Zhang Y, Wang X, Peng X, Meng C. The effect of microRNAs in the regulation of human CYP3A4: a systematic study using a mathematical model. Sci Rep 2014;4:4283.
51. Lu M, Jolly MK, Levine H, Onuchic JN, Ben-Jacob E. MicroRNAbased regulation of epithelial-hybrid-mesenchymal fate determination. Proc Natl Acad Sci U S A 2013;110:18144-9.
52. Andrecut M, Halley JD, Winkler DA, Huang S. A general model for binary cell fate decision gene circuits with degeneracy: indeterminacy and switch behavior in the absence of cooperativity. PLoS ONE 2011;6:e19358.
53. Guantes R, Poyatos JF. Multistable decision switches for flexible control of epigenetic differentiation. PLoS Comput Biol 2008;4: e1000235.
54. Macía J, Widder S, Solé R. Why are cellular switches Boolean? General conditions for multistable genetic circuits. J Theor Biol 2009; 261:126-35.
55. Wang J, Zhang K, Xu L, Wang E. Quantifying the Waddington landscape and biological paths for development and differentiation. Proc Natl Acad Sci U S A 2011;108:8257-62.
56. García de Herreros A, Baulida J. Cooperation, amplification, and feed-back in epithelial-mesenchymal transition. Biochim Biophys Acta 2012;1825:223-8.
57. Frisch SM. The epithelial cell default-phenotype hypothesis and its implications for cancer. Bioessays 1997;19:705-9.
58. Das S, Becker BN, Hoffmann FM, Mertz JE. Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway. BMC Cell Biol 2009;10:94.
59. Aigner K, Dampier B, Descovich L, Mikula M, Sultan A, Schreiber M, et al. The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 2007;26:6979-88.
60. Taube JH, Herschkowitz JI, Komurov K, Zhou AY, Gupta S, Yang J, et al. Core epithelial-to-mesenchymal transition interactome geneexpression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci U S A 2010;107: 15449-54.
61. Vannier C, Mock K, Brabletz T, Driever W. Zeb1 regulates E-cadherin and Epcam (epithelial cell adhesion molecule) expression to control cell behavior in early zebrafish development. J Biol Chem 2013;288:18643-59.
62. Chigurupati S, Arumugam TV, Son TG, Lathia JD, Jameel S, Mughal MR, et al. Involvement of notch signaling inwound healing. PLoSONE 2007;2:e1167.
63. Huang RY-J, Wong MK, Tan TZ, Kuay KT, Ng AHC, Chung VY, et al. An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530). Cell Death Dis 2013;4:e915.
64. Batlle E, Sancho E, Francí C, Domínguez D, Monfar M, Baulida J, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000;2:84-9.
65. Blanco MJ, Barrallo-Gimeno A, Acloque H, Reyes AE, Tada M, Allende ML, et al. Snail1a and Snail1b cooperate in the anterior migration of the axial mesendoderm in the zebrafish embryo. Development 2007;134:4073-81.
66. Savagner P, Kusewitt DF, Carver EA, Magnino F, Choi C, Gridley T, et al. Developmental transcription factor slug is required for effective re-epithelialization by adult keratinocytes. J Cell Physiol 2005; 202:858-66.
67. Kong D, Banerjee S, Ahmad A, Li Y, Wang Z, Sethi S, et al. Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. PLoS ONE 2010;5: e12445.
68. Yang X, Lin X, Zhong X, Kaur S, Li N, Liang S, et al. Double-negative feedback loop between reprogramming factor LIN28 and microRNA let-7 regulates aldehyde dehydrogenase 1-positive cancer stem cells. Cancer Res 2010;70:9463-72.
69. Li Y, VandenBoom TG, Kong D, Wang Z, Ali S, Philip PA, et al. Upregulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res 2009;69:6704-12.
70. Tokumaru S, Suzuki M, Yamada H, Nagino M, Takahashi T. let-7 regulates Dicer expression and constitutes a negative feedback loop. Carcinogenesis 2008;29:2073-7.
71. Zisoulis DG, Chang RK, Kai ZS, Pasquinelli AE. Autoregulation of microRNA biogenesis by let-7 and Argonaute. Nature 2012;486: 541-4.
72. Massirer KB, Yeo GW, Morris Q, Hutt KR, Yan BY, Kazan H, et al. LIN28 binds messenger RNAs at GGAGA motifs and regulates splicing factor abundance. Mol Cell 2012;48:195-206.
73. Qiu C, Ma Y, Wang J, Peng S, Huang Y. Lin28-mediated posttranscriptional regulation of Oct4 expression in human embryonic stem cells. Nucleic Acids Res 2010;38:1240-8.
74. Wang G, Guo X, Hong W, Liu Q, Wei T, Lu C, et al. Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-toepithelial transition and induced pluripotent stem cell generation. Proc Natl Acad Sci U S A 2013;110:2858-63.
75. Dangi-Garimella S, Yun J, Eves EM, Newman M, Erekland SJ, Hammond SM, et al. Raf kinase inhibitory protein suppresses a metastasis signaling cascade involving LIN28 and let-7. EMBO J 2009;28:347-58.
76. Lee J, Lee J, Farquhar KS, Yun J, Frankenberger CA, Bevilacqua E, et al. Network of mutually repressive metastasis regulators can promote cell heterogeneity and metastatic transitions. Proc Natl Acad Sci U S A 2014;111:E364-73.
77. Kim D, Kim S, Jin E-J, Park HM, Sonn J, Song J, et al. MicroRNA-34a modulates cytoskeletal dynamics through regulating RhoA/Rac1 cross-talk in chondroblasts. J Biol Chem 2012;287:12501-9.
78. Elson-Schwab I, Lorentzen A, Marshall CJ. MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion. PLoS ONE 2010;5:e13176.
79. Parri M, Chiarugi P. Rac and Rho GTPases in cancer cell motility control. Cell Commun Signal 2010;8:23.
80. Ben-Jacob E, Coffey DS, Levine H. Bacterial survival strategies suggest rethinking cancer cooperativity. Trends Microbiol 2012;20: 403-10.
81. Eades G, Yao Y, Yang M, Zhang Y, Chumsri S, Zhou Q. miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells. J Biol Chem 2011;286:25992-6002.
82. Brooks CL, Gu W. How does SIRT1 affect metabolism, senescence and cancer? Nat Rev Cancer 2009;9:123-8.
83. Lim J-H, Lee Y-M, Chun Y-S, Chen J, Kim J-E, Park J-W. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxiainducible factor 1alpha. Mol Cell 2010;38:864-78.
84. Dioum EM, Chen R, Alexander MS, Zhang Q, Hogg RT, Gerard RD, et al. Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1. Science 2009;324: 1289-93.
85. Wang RH, Sengupta K, Li C, Kim HS, Cao L, Xiao C, et al. Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell 2008;14:312-23.
86. Kim WY, Perera S, Zhou B, Carretero J, Yeh JJ, Heathcote SA, et al. HIF2alpha cooperates with RAS to promote lung tumorigenesis in mice. J Clin Invest 2009;119:2160-70.
87. Yuan G, Peng YJ, Reddy VD, Makarenko VV, Nanduri J, Khan SA, et al. Mutual antagonism between hypoxia-inducible factors 1a and 2a regulates oxygen sensing and cardio-respiratory homeostasis. Proc Natl Acad Sci U S A 2013;110:E1788-96.
88. Magenta A, Cencioni C, Fasanaro P, Zaccagnini G, Greco S, Sarra- Ferraris G, et al. miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition. Cell Death Differ 2011;18:1628-39.
89. Fukawa T, Kajiya H, Ozeki S, Ikebe T, Okabe K. Reactive oxygen species stimulates epithelial mesenchymal transition in normal human epidermal keratinocytes via TGF-beta secretion. Exp Cell Res 2012;318:1926-32.
90. Lin Q, Cong X, Yun Z. Differential hypoxic regulation of hypoxiainducible factors 1alpha and 2alpha. Mol Cancer Res 2011;9: 757-65.
91. Koh MY, Lemos R, Liu X, Powis G. The hypoxia-associated factor switches cells from HIF-1a- to HIF-2a-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion. Cancer Res 2011;71:4015-27.
92. Seidel S, Garvalov BK, Wirta V, von Stechow L, Schänzer A, Meletis K, et al. A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha. Brain 2010;133:983-95.
93. Bar EE, Lin A, Mahairaki V, Matsui W, Eberhart CG. Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. Am J Pathol 2010;177: 1491-502.
94. Schliekelman MJ, Gibbons DL, Faca VM, Creighton CJ, Rizvi ZH, Zhang Q, et al. Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer. Cancer Res 2011;71:7670-82.
95. Pecot CV, Rupaimoole R, Yang D, Akbani R, Ivan C, Lu C, et al. Tumour angiogenesis regulation by the miR-200 family. Nat Commun 2013;4:2427.
96. Cieply B, Farris J, Denvir J, Ford HL, Frisch SM. Epithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2. Cancer Res 2013;73:6299-309.
97. Roca H, Hernandez J, Weidner S, McEachin RC, Fuller D, Sud S, et al. Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer. PLoS ONE 2013;8:e76773.
98. Moes M, Le Béchec A, Crespo I, Laurini C, Halavatyi A, Vetter G, et al. A novel network integrating a miRNA-203/SNAI1 feedback loop which regulates epithelial to mesenchymal transition. PLoS ONE 2012;7:e35440.
99. Vallejo DM, Caparros E, Dominguez M. Targeting Notch signalling by the conserved miR-8/200 microRNA family in development and cancer cells. EMBO J 2011;30:756-69.
100. Leopold PL, Vincent J, Wang H. A comparison of epithelial-tomesenchymal transition and re-epithelialization. Semin Cancer Biol 2012;22:471-83.